170413 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines Chemokines
Sub-classes:BIOMARKERS IN LONG-COVID-19
#2METHODS OF FORMING PATIENT-DERIVED 3D CELL CULTURES FOR TRACKING LIVE IMMUNE-TUMOR INTERACTIONS
#3METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#4PROTEIN MARKER PANEL FOR SCREENING CLINICAL FUTILE RECANALIZATION (FR) IN LARGE VESSEL OCCLUSION-INDUCED ACUTE ISCHEMIC STROKE (LVO-AIS) AND USE THEREOF
#5Skeletal Muscle-On-A-Chip In Microgravity As A Platform For Regeneration Modeling And Drug Screening
#6COMBINED INVASTION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING TARGET CELLS
#7MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#8METHODS RELATING TO DIAGNOSING STABILITY FOLLOWING RENAL TRANSPLANTATION
#9METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID
#10TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#11METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING PERSISTENT ACUTE KIDNEY INJURY BASED ON C-C MOTIF CHEMOKINE LIGAND 14 MEASUREMENT
#12ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF
#13METHOD OF CHARACTERIZING TUMORS
#14METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
#15METHODS AND MATERIALS FOR IDENTIFYING AND TREATING VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA
#16BIOMARKERS FOR THE DETERMINATION OF SAMPLE ADEQUACY AND LUNG CANCER METASTASES
#17BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE
#18IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS
#19USE OF TCTP AS BIOMARKER FOR PREDICTING EFFICACY, PROGNOSIS OF IMMUNOTHERAPY OR RESISTANCE THERETO, AND TARGET OF IMMUNOTHERAPY FOR ENHANCING EFFICACY
#20MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION
#21Prediction of Severity of COVID-19 and Methods of Treatment
#22EARLY DIAGNOSIS OF INFECTIONS
#23EX VIVO MODEL OF INFLAMED HUMAN SKIN AND USES THEREOF FOR SCREENING ANTI-INFLAMMATORY COMPOUNDS
#24SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#25HUMAN CXCLI6 ANTIBODIES AND THE USE THEREOF
#26SCREENING DONOR LUNGS FOR LUNG TRANSPLANTATION
#27COMPOSITION CONTAINING TARC, DILUENT, METHOD FOR REDUCING TARC CARRYOVER, ADSORPTION INHIBITOR, AND CONTINUOUS ANALYSIS METHOD
#28DIAGNOSTIC METHODS FOR HIDRADENITIS SUPPURATIVA
#29IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT
#30Cardiovascular Disease
#31BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT
#32MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
#33METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#34LUNG-CANCER SPECIFIC T CELL DYSFUNCTION
#35BIOMARKER COMBINATIONS TO SIMULTANEOUSLY EVALUATE NON-ALCOHOLIC STEATOHEPATITIS AND HEPATIC FIBROSIS STATUS
#36CXCL10 BINDING PROTEINS AND USES THEREOF
#37TESTING COLON CANCER DRUGS FOR IMMUNOMODULATORY EFFECTS
#38USE OF STROMAL CELL-DERIVED FACTOR 1 (SDF1) AS A BIOMARKER FOR DIAGNOSING AND TREATING SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
#39Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19
#40TREATMENT OF CASTLEMAN DISEASE
#41BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY
#42EGG, FERTILIZED EGG, OR EMBRYO QUALITY IMPROVING AGENT
#43METHOD FOR DETERMINING THE FREE ANTIGEN OF AN ANTIBODY IN A SAMPLE
#44METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
#45CXCL14 AS PREDICTIVE BIOMARKER FOR ACUTE LIVER FAILURE AND DEATH
#46SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#47DETECTING SEPSIS
#48BIOMARKERS FOR PREDICTING THE RESPONSE TO CHECKPOINT INHIBITORS
#49CXCL10 binding proteins and compositions thereof
#50Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#51Methods and compositions for evaluation and treatment of renal injury and renal failure based on C-C motif chemokine ligand 14 measurement
#52Pulmonary hypertension biomarker
#53DEVICE AND METHOD FOR DETECTING INFLAMMATION
#54Methods of assigning a COVID pathological type based on a cytokine/chemokine panel
#55Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#56Early diagnosis of infections
#57TREATMENT OF AUTOIMMUNE LIVER DISEASE
#58Biomarkers and methods for detection of seizures and epilepsy
#59Method for treating cancer based on expression levels of translationally controlled tumor protein (TCTP)
#60MARKERS AND THEIR USE IN BRAIN INJURY
#61METHODS OF DETECTING AND DIAGNOSING DEFECTS OF THE LYMPHATIC VASCULATURE
#62BIOMARKERS
#63BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#64Compositions and Methods for Discriminating Infectious from Non-Infectious CNS Disorders
#65Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist
#66METHOD FOR OBTAINING INFORMATION ON RISK OF REDUCED RESPIRATORY FUNCTION IN PATIENT WITH INTERSTITIAL PNEUMONIA
#67COMBINED INVASION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING TARGET CELLS
#68Anti-CXCL13 antibodies for treating autoimmune diseases and cancer
#69PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
#70Methods for detecting and treating cancers having adenosine pathway activation
#71Methods of prognosis and treatment
#72CCL24 as a diagnostic and therapeutic target for breast cancer
#73Biomarkers for graft-versus-host disease
#74Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
#75Egg, fertilized egg, or embryo quality improving agent
#76Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#77BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER
#78Treatment of cancers using PI3 kinase isoform modulators
#79CANCER SERUM BIOMARKERS AND METHODS OF USE THEREOF
#80BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#81QUANTITATIVE BIOMARKERS OF EHV-1 SUSCEPTIBILITY AND PROTECTION
#82Anti-CXCL13 antibodies
#83METHOD FOR DETERMINING A TISSUE INJURY AND REPAIR (TIAR) PROCESS ASSOCIATED WITH ABNORMAL FORMATION OF ENDOMETRIAL TISSUE
#84Minimally-invasive measurement of esophageal inflammation
#85METHODS OF PRODUCING CIRCULATING ANALYTE PROFILES AND DEVICES FOR PRACTICING SAME
#86Biomarkers and methods for detection of seizures and epilepsy
#87CCL20 as a predictor of clinical response to IL23-antagonists
#88AGENT FOR CONTROLLING CELLS CONSTITUTING CANCER MICROENVIRONMENT OR INFLAMMATORY MICROENVIRONMENT
#89Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
#90Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer
#91Biomarkers in autoimmune liver disease
#92DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#93METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS
#94MARKERS AND THEIR USE IN BRAIN INJURY
#95Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#96SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#97METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#98Biomarker Panel For Diagnosing Cancer
#99METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#100PULMONARY HYPERTENSION BIOMARKER
#101METHOD FOR TREATING EPSTEIN-BARR VIRUS - POSITIVE CANCER WITH IMMUNOTHERAPY
#102Method for treating cancer using chemokine antagonists
#103Biomarkers for anti-IL4-IL13 bispecific antibodies
#104Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#105Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement
#106PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE TO ANTI-LPS IMMUNOGLOBULIN TREATMENT
#107Elevated CCL19 after completion of therapy for acute lyme disease identifies patients at risk for development of post-treatment lyme disease syndrome who will benefit from further antibiotic therapy
#108DETECTING SEPSIS
#109Biomarkers for diagnosing post traumatic stress disorder
#110METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS
#111Minimally-invasive measurement of esophageal inflammation
#112COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS
#113Platelet biomarkers and diagnostic methods for vascular diseases
#114PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS
#115Biomarkers for seizures
#116CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
#117MARKERS AND THEIR USE IN BRAIN INJURY
#118Polypeptide having chemokine activity and uses thereof
#119Methods and compositions for treatment of autoimmune hepatitis
#120Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#121Method and kit for determining the probability that a patient will develop a severe case of dengue
#122Cardiovascular risk event prediction and uses thereof
#123Future cardiac event biomarkers CCL3, CCL5, and CCL18
#124Cytokine
#125Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
#126Biomarker panel for diagnosing cancer
#127CXCR4 binding molecules and methods of use thereof
#128Methods for treating or preventing asthma by administering an IL-4R antagonist
#129TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#130Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
#131Agent for controlling cells constituting cancer microenvironment or inflammatory microenvironment
#132Biomarkers for seizures
#133Method for treating epstein-barr virus—positive cancer with immunotherapy
#134METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#135Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#136METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#137Methods of treatment of primary sclerosing cholangitis
#138Devices and methods for the rapid and accurate detection of analytes
#139Method for treating cancer using chemokine antagonists
#140PULMONARY HYPERTENSION BIOMARKER
#141Minimally-invasive measurement of esophageal inflammation
#142METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#143COMPOSITIONS COMPRISING GLUTEN PEPTIDES AND USES THEREOF
#144COMPOSITION OR KIT FOR DIAGNOSING COLORECTAL CANCER INCLUIDNG CXCL7-MEASURING AGENT AND METHOD OF DIAGNOSING COLORECTAL CANCER USING THE SAME
#145Method and kit for determining the probability that a patient will develop a severe case of dengue
#146LKB1 related diagnostics and treatments of cancer
#147Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial lung disease
#148Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
#149ELEVATED CCL19 AFTER COMPLETION OF THERAPY FOR ACUTE LYME DISEASE IDENTIFIES PATIENTS AT RISK FOR DEVELOPMENT OF POST-TREATMENT LYME DISEASE SYNDROME WHO WILL BENEFIT FROM FURTHER ANTIBIOTIC THERAPY
#150METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#151Biomarkers for seizures
#152BIOMARKERS FOR SEIZURES
#153Biological markers useful in cancer immunotherapy
#154Assay for determining endogenous levels of analyte in vivo
#155FUTURE CARDIAC EVENT BIOMARKERS
#156Neutralizing anti-CCL20 antibodies
#157CCL22 and CCL17 cancer biomarkers
#158Methods and compositions for diagnosis of inflammatory liver disease
#159DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#160Renal Cell Carcinoma Biomarkers and Uses Thereof
#161CANCER PROGNOSTIC ASSAYS
#162Cytokine
#163METHODS AND PRODUCTS RELATED TO LUNG CANCER
#164DIAGNOSIS AND TREATMENT OF TRAUMATIC BRAIN INJURY
#165Methods for treatment of age-related macular degeneration
#166Renal Cell Carcinoma Biomarkers and Uses Thereof
#167Methods for prevention and treatment of inflammation using anti-chemokine antibodies
#168BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES
#169Methods for Monitoring Allograft Rejection
#170Neutralizing anti-CCL20 antibodies
#171DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#172Semi-Invasive Method for Characterizing Lung Injury
#173THERAPEUTICS FOR AGE-RELATED MACULAR DEGENERATION
#174CXCL4L1 AS A BIOMARKER OF PANCREATIC CANCER
#175METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#176Methods for prevention and treatment of inflammation using anti-chemokine antibodies
#177METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#178Cytokine
#179Future cardiac event biomarkers CCL3, CCL5 and CCL18
#180CCL18 and CCL3 methods and compositions for detecting and treating cancer
#181Minimally-invasive measurement of esophageal inflammation
#182Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
#183METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES
#184Systems And Methods For Characterizing Contrast Induced-Nephropathy